Preclinical biotech developing therapies based on single-base gene editing.
Industry: Health Care
First Day Return: +10.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/27/2019 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 10.6 |
Deal Size ($mm) | $180 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/05/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $180 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2017 |
Employees at IPO | 87 |
Website www.beamtx.com |